8-K/AEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K/A Report, Financial Results (Apr 22, 2022)

Filed April 22, 2022For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K/A on April 21, 2022, to amend a previous filing and furnish a press release from April 20, 2022. This press release detailed the company's financial results for the quarter ended March 31, 2022. Investors should note that the information provided in this press release is furnished and not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it doesn't carry the same legal implications for misstatements as filed reports. The report also includes standard forward-looking statements and a comprehensive list of risk factors that could impact future performance. While the 8-K/A itself is procedural, the key takeaway for investors lies within the furnished press release, which would contain the actual financial performance data for the first quarter of 2022. Investors should refer to Exhibit 99.1 for the specific details regarding revenue, earnings, membership, and any forward-looking guidance provided by Elevance Health. The included risk factors highlight potential challenges such as the impact of healthcare costs, regulatory changes (including the ACA), PBM business risks, and potential cybersecurity threats, all of which are crucial for a comprehensive understanding of the company's operating environment.

Key Highlights

  • 1Filing is an amendment (8-K/A) to a prior report.
  • 2Furnishes a press release dated April 20, 2022, detailing Q1 2022 financial results.
  • 3Information furnished in Item 2.02 and Exhibit 99.1 is not deemed 'filed' under Section 18 of the Securities Exchange Act.
  • 4The press release (Exhibit 99.1) contains the company's financial results for the quarter ended March 31, 2022.
  • 5Includes a comprehensive list of forward-looking statements and associated risk factors.
  • 6Key risks mentioned include healthcare cost trends, regulatory changes, PBM business operations, and cybersecurity.
  • 7Company was formerly known as Anthem, Inc., with the name change to Elevance Health, Inc. implied by the filing context and press release.

Frequently Asked Questions

This 8-K/A filing serves to formally furnish a press release from April 20, 2022, which contains Elevance Health's financial results for the first quarter ended March 31, 2022. It is an amendment to a previous filing, indicating a procedural update or addition of this information.

The specific financial results for the quarter ended March 31, 2022, are detailed in the press release furnished as Exhibit 99.1 to this 8-K/A filing. Investors should refer to this exhibit for detailed financial performance metrics.

No, the information furnished in Item 2.02 and Exhibit 99.1 is explicitly stated as not being 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same liability for misstatements as information formally filed with the SEC.

Elevance Health highlights a broad range of risks, including but not limited to: the impact of large-scale medical emergencies like pandemics, fluctuating healthcare costs and utilization rates, regulatory changes (such as the ACA), competitive pressures, cybersecurity threats, risks associated with their Pharmacy Benefit Management (PBM) business, and potential changes in government programs like Medicare and Medicaid.